[1] American Joint Committee on Cancer. Updates to AJCC 8th Edition: Gallbladder Cancer Staging (2023) [EB/OL]. [2024-05-01] https://www.facs.org/quality-programs/cancer-programs/ajcc/
[2] 付佳禄, 李起, 张东, 等. 《胆囊癌诊断和治疗指南》(2019版)更新解读[J]. 肝胆胰外科杂志, 2020, 32(11): 659-663, 666.
[3] 李斌, 姜小清. 胆囊癌的规范化手术治疗[J]. 中国普外基础与临床杂志, 2019, 26(3): 265-269.
[4] 中国抗癌协会. 中国恶性肿瘤整合诊治指南:胆囊癌[J]. 肿瘤, 2022, 42(3): 188-202.
[5] Chaudhari VA, Ostwal V, Patkar S, et al.Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications[J]. HPB (Oxford), 2018, 20(9): 841-847.
[6] Wang Y, Zhang N, Xue J, et al.Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC[J]. Front Immunol, 2023, 14: 1084843.
[7] Shi GM, Huang XY, Wu D, et al.Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study[J]. Signal Transduct Target Ther, 2023, 8(1): 106.
[8] Zhu C, Xue J, Wang Y, et al.Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer[J]. Front Immunol, 2023, 14: 1109292.
[9] Fujiwara Y, Horita N, Harrington M, et al.Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials[J]. Cancer Immunol Immunother, 2022, 71(12): 2837-2848.
[10] Fujiwara Y, Horita N, Harrington M, et al.Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials[J]. Cancer Immunol Immunother, 2022, 71(12): 2837-2848.
[11] D'Hondt M, Lapointe R, Benamira Z, et al. Carcinoma of the gallbladder: Patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience[J]. Eur J Surg Oncol, 2013, 39(6): 548-553.
[12] Misra S, Chaturvedi A, Misra NC, et al.Carcinoma of the gallbladder[J]. Lancet Oncol, 2003, 4(3): 167-176. |
